EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence

Zohra Nausheen Nizami iD, Hanan E Aburawi iD, Abdelhabib Semlali iD, Khalid Muhammad iD, Rabah Iratni iD

Antioxidants · 26.05.2023 · 12 (6) · 1159

DOI: 10.3390/antiox12061159 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 26.05.2023. Verfasst von Zohra Nausheen Nizami und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, United Arab Emirates University, Al Ain PO Box 15551, United Arab Emirates. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reactive oxygen species (ROS) are metabolic byproducts that regulate various cellular processes. However, at high levels, ROS induce oxidative stress, which in turn can trigger cell death. Cancer cells alter the redox homeostasis to facilitate protumorigenic processes; however, this leaves them vulnerable to further increases in ROS levels. This paradox has been exploited as a cancer therapeutic strategy with the use of pro-oxidative drugs. Many chemotherapeutic drugs presently in clinical use, such as cisplatin and doxorubicin, induce ROS as one of their mechanisms of action. Further, various drugs, including phytochemicals and small molecules, that are presently being investigated in preclinical and clinical studies attribute their anticancer activity to ROS induction. Consistently, this review aims to highlight selected pro-oxidative drugs whose anticancer potential has been characterized with specific focus on phytochemicals, mechanisms of ROS induction, and anticancer effects downstream of ROS induction.

Schlagwörter

Stichwörter der Autor:innen

cancer therapyoxidative stressphytochemicalsreactive oxygen species

Autor:innen und Institutionen

  • Department of Biology, College of Science, United Arab Emirates University, Al Ain PO Box 15551, United Arab Emirates.
  • Groupe de Recherche en Écologie Buccale, Faculté de Médecine Dentaire-Université Laval, Quebec, QC G1V 0A6, Canada.

ORCID-Profile: Zohra Nausheen Nizami, Hanan E Aburawi, Abdelhabib Semlali, Khalid Muhammad, Rabah Iratni

Zitieren

APA

Nizami, Z. N., Aburawi, H. E., Semlali, A., Muhammad, K., & Iratni, R. (2023). Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence. Antioxidants, 12(6), 1159. https://doi.org/10.3390/antiox12061159

Vancouver

Nizami ZN, Aburawi HE, Semlali A, Muhammad K, Iratni R. Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence. Antioxidants. 2023;12(6):1159. doi:10.3390/antiox12061159

BibTeX
@article{Nizami2023,
  author = {Nizami, Zohra Nausheen and Aburawi, Hanan E and Semlali, Abdelhabib and Muhammad, Khalid and Iratni, Rabah},
  title = {Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence},
  journal = {Antioxidants},
  year = {2023},
  volume = {12},
  number = {6},
  pages = {1159},
  doi = {10.3390/antiox12061159}
}
Kostenlos starten →